📰 Session Title News
Session Title News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Session Title. Real-time updates on events, politics, business and more.
May 23, 2024
Emerging clinical pharmacokinetic and safety profiles of Bicycle Toxin Conjugates demonstrate differentiation compared to antibody drug conjugates Trial-in-progress poster outlines registrational
May 23, 2024
23.05.2024 - Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced that emerging Phase 1/2 clinical ... Seite 1
May 23, 2024
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--May 23, 2024--
May 1, 2024
MELBOURNE, Australia and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT, the "Company")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent
April 24, 2024
Bicycle Therapeutics plc , a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, today announced the acceptance...
March 25, 2024
ProteinQure Announces A Breakthrough Therapeutic with Remarkable Efficacy ...
October 30, 2023
Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced presentations at the American Academy of Ophthalmology (AAO) 2023 Annual Meeting and Eyecelerator @ AAO 2023 taking place in San Francisco, California. Details for the presentations are as follows:
June 20, 2023
Edmond, Oklahoma -- The Commercial Real Estate Summit Foundation™ is hosting their ninth annual statewide Commercial Real Estate Summit™ on Wednesday, Oct. 11, 2023 at the University of Central Oklahoma
June 12, 2023
12.06.2023 - Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was ...
May 31, 2023
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that seven abstracts featuring new data from across its sleep medicine portfolio will...